Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    NIAID | Open Studies | diabetes
Show Display Options
RSS Create an RSS feed from your search for:
NIAID | Open Studies | diabetes
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting TCZ in New-onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Tocilizumab;   Drug: Placebo for Tocilizumab
2 Recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
3 Recruiting Natural History Study of the Development of Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention:
4 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
5 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
6 Not yet recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG)/Placebo;   Drug: Granulocyte colony stimulating factor (GCSF)
7 Recruiting T and B Cell Responses Across Autoimmune Diseases
Conditions: Type 1 Diabetes Mellitus;   Multiple Sclerosis;   Arthritis, Rheumatoid;   Crohn Disease;   Psoriasis
Intervention:
8 Not yet recruiting Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Conditions: Human Immunodeficiency Virus Infection;   Diabetes Mellitus
Intervention: Drug: extended-release exenatide
9 Recruiting Non‐Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population
Conditions: Antiretroviral Therapy, Highly Active;   Diabetes Mellitus, Type 2;   Cardiovascular Diseases
Intervention: Behavioral: Referral for NCD care

Indicates status has not been verified in more than two years